1HVR
RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS
Summary for 1HVR
Entry DOI | 10.2210/pdb1hvr/pdb |
Descriptor | HIV-1 PROTEASE, [4R-(4ALPHA,5ALPHA,6BETA,7BETA)]-HEXAHYDRO-5,6-DIHYDROXY-1,3-BIS[2-NAPHTHYL-METHYL]-4,7-BIS(PHENYLMETHYL)-2H-1,3-DIAZEPIN-2-ONE (2 entities in total) |
Functional Keywords | hydrolase, acid proteinase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Human immunodeficiency virus 1 |
Cellular location | Gag-Pol polyprotein: Host cell membrane; Lipid-anchor . Matrix protein p17: Virion membrane; Lipid- anchor . Capsid protein p24: Virion . Nucleocapsid protein p7: Virion . Reverse transcriptase/ribonuclease H: Virion . Integrase: Virion : P04585 |
Total number of polymer chains | 2 |
Total formula weight | 22154.08 |
Authors | Chang, C.-H. (deposition date: 1994-02-14, release date: 1995-01-26, Last modification date: 2017-11-29) |
Primary citation | Lam, P.Y.,Jadhav, P.K.,Eyermann, C.J.,Hodge, C.N.,Ru, Y.,Bacheler, L.T.,Meek, J.L.,Otto, M.J.,Rayner, M.M.,Wong, Y.N.,Chang, C.-H.,Weber, P.,Jackson, D.A.,Sharpe, T.R.,Erickson-Viitanen, S. Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. Science, 263:380-384, 1994 Cited by PubMed: 8278812PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.8 Å) |
Structure validation
Download full validation report